Acetylcysteine protects patients with moderate chronic renal insufficiency from contrast-induced deterioration in renal function after coronary angiographic procedures, with minimal adverse effects and at a low cost.
date_rangeJul 22' 2019 / India
date_rangeFeb 13' 2019 / India
date_rangeFeb 12' 2019 / India
date_rangeJan 25' 2019 / India